186 related articles for article (PubMed ID: 22083202)
1. [A case of lung cancer showing marked reduction of pleural effusion by bevacizumab in combination with carboplatin and paclitaxel].
Hama M; Komatsu Y; Hachiya T
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1877-9. PubMed ID: 22083202
[TBL] [Abstract][Full Text] [Related]
2. [Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer].
Ishiura Y; Yamamoto H; Terasaki Y; Ishida Y; Tohge M; Segawa M; Kusajima Y; Saitoh K; Ishikawa M; Hirokami N; Kasahara K; Fujimura M
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2631-3. PubMed ID: 22189231
[TBL] [Abstract][Full Text] [Related]
3. [A case of complete resection of non-squamous non-small-cell lung cancer after induction chemotherapy using carboplatin, paclitaxel, and bevacizumab].
Kawaharada Y; Imai K; Minamiya Y; Saito H; Konno H; Fujishima S; Ogawa J
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1533-7. PubMed ID: 23064066
[TBL] [Abstract][Full Text] [Related]
4. [A case of lung cancer in an elderly patient with malignant pleural effusion and pneumothorax treated with carboplatin, pemetrexed, and bevacizumab].
Miyahara E; Itagaki T; Kuwahara M; Kameda A; Oue N
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1237-40. PubMed ID: 25335706
[TBL] [Abstract][Full Text] [Related]
5. [A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy].
Nakamura S; Horiuchi N; Katsura D; Shichijo K; Yoshida S; Harada E; Matsushita T; Oshima Y; Matsuzaki Y; Tamaki Y; Kimura S; Takeichi T; Fujimoto H; Masuda K; Iwasaka N; Shinomiya S
Gan To Kagaku Ryoho; 2008 Jun; 35(6):965-8. PubMed ID: 18633226
[TBL] [Abstract][Full Text] [Related]
6. [A case of sarcomatoid carcinoma of the lung successfully treated with carboplatin, paclitaxel and bevacizumab].
Sugano T; Mori M; Namba Y; Uenami T; Kagami S; Yokota S
Nihon Kokyuki Gakkai Zasshi; 2011 Apr; 49(4):304-8. PubMed ID: 21591461
[TBL] [Abstract][Full Text] [Related]
7. [A case of non-small cell lung carcinoma successfully treated with carboplatin and weekly paclitaxel under renal dysfunction].
Mori M; Takeda E; Sakai K; Nishida Y; Tamura K; Akedo I; Yanagi K; Nakagawa C; Tsugawa M; Ono H; Kubo M
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2061-4. PubMed ID: 15570941
[TBL] [Abstract][Full Text] [Related]
8. FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.
Cohen MH; Gootenberg J; Keegan P; Pazdur R
Oncologist; 2007 Jun; 12(6):713-8. PubMed ID: 17602060
[TBL] [Abstract][Full Text] [Related]
9. Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient.
Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
Gan To Kagaku Ryoho; 2007 Feb; 34(2):225-7. PubMed ID: 17301532
[TBL] [Abstract][Full Text] [Related]
10. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
[TBL] [Abstract][Full Text] [Related]
11. [A case of advanced ovarian clear cell adenocarcinoma responding to cisplatin-cyclophosphamide and paclitaxel-carboplatin].
Iwasaki K; Komuro Y; Masumoto N; Asaoka K; Ishitani K
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1483-6. PubMed ID: 10500539
[TBL] [Abstract][Full Text] [Related]
12. [A retrospective study of carboplatin and weekly paclitaxel combination chemotherapy for elderly patients with advanced non-small cell lung cancer].
Mito A; Yamasaki M; Ohashi N; Kajihara T; Nitta T; Awaya H; Ikegami Y; Arita K
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1707-11. PubMed ID: 20841932
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
Langer CJ; Leighton J; McAleer C; Comis R; O'Dwyer P; Ozols R
Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
Chiappori AA; Haura E; Rodriguez FA; Boulware D; Kapoor R; Neuger AM; Lush R; Padilla B; Burton M; Williams C; Simon G; Antonia S; Sullivan DM; Bepler G
Clin Cancer Res; 2008 Mar; 14(5):1464-9. PubMed ID: 18316570
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of recurrent invasive mucinous adenocarcinoma of the lung showing marked responses to platinum-based chemotherapyregimens with pemetrexed and bevacizumab].
Koma Y; Nakashima N; Koyama M; Goto K; Yokota N; Kimura K; Matsumoto Y; Yoshida C; Matsuoka H; Masuya D; Yoshimatsu H; Suzuki Y
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1525-8. PubMed ID: 24231707
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab, Carboplatin and Paclitaxel Combination Treatment in Advanced Stage Ovarian Cancer: The First Experience in Thammasat University Hospital, Thailand: A Case Report.
Suwannarurk K; Thaweekul Y; Mairaing K; Poomtavorn Y; Tangtiang K; Piyawang W; Bhamarapravatana K
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S121-5. PubMed ID: 26387399
[TBL] [Abstract][Full Text] [Related]
18. [A case of lung adenocarcinoma associated with remarkably high levels of CA 19-9 and lymphangitis carcinomatosa].
Akiyama Y; Kondo H; Shirono R; Fujii Y
Gan To Kagaku Ryoho; 1997 Jan; 24(1):93-6. PubMed ID: 9020951
[TBL] [Abstract][Full Text] [Related]
19. An indirect comparison of the efficacy of bevacizumab plus carboplatin and paclitaxel versus pemetrexed with cisplatin in patients with advanced or recurrent non-squamous adenocarcinoma non-small cell lung cancer.
Nuijten MJ; Aultman R; Carpeño Jde C; Vergnenègre A; Chouaid C; Walzer S; Siebert U
Curr Med Res Opin; 2011 Nov; 27(11):2193-201. PubMed ID: 21970659
[TBL] [Abstract][Full Text] [Related]
20. [A case of recurrent invasive thymic cancer showing a stable disease to carboplatin plus paclitaxel].
Igawa S; Yanagisawa N; Makita S; Iida Y; Maki S; Kimura Y; Otani S; Hayashi N; Takakura A; Katono K; Onoda S; Yamamoto M; Masuda N
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2161-3. PubMed ID: 21084818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]